MannKind Corp (MNKD)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.27B
Last updated: Nov 17, 2026 at 4:40 PM ET
MannKind Corp (MNKD) Statistics
MannKind (MNKD) has a market cap of $1.27B and an enterprise value of $1.55B. Revenue grew 31.74% over the last 12 months from the 12 months before. Its share count is up 4.36% from a year earlier.
Total Valuation
Enterprise value is 21.87% above the market cap, as debt exceeds cash.
| Market Cap | $1.27B |
|---|---|
| Enterprise Value | $1.55B |
| Latest price (Nov 17, 2026) | $4.07 |
Key Dates
The next earnings report is expected on Feb 24, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 24, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 5, 2026 |
| Fiscal Year End | December |
Valuation Ratios
The price to sales ratio is 3.2x. Its year-end P/S ranged from 1.7x to 20.8x from 2016 to 2025.
| P/S Ratio | 3.2x |
|---|---|
| Forward P/S | 2.9x |
Price Statistics
The stock is down 19.57% over 52 weeks and trades 14.01% above its 50-day average.
| Beta (1Y) | 0.99 |
|---|---|
| 52-Week Change | -19.57% |
| 1-Month Change | +31.72% |
| 3-Month Change | -7.39% |
| 6-Month Change | +37.50% |
| 5-Year Change | -25.69% |
| 10-Year Change | +67.79% |
| Total Return (1Y) | -19.57% |
| Total Return (3Y CAGR) | +2.31% |
| Total Return (5Y CAGR) | -2.88% |
| Return vs SPY (1Y) | -31.12% |
| Max Drawdown (1Y) | -63.29% |
| Max Drawdown (3Y) | -69.35% |
| Sharpe Ratio (1Y) | -0.29 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $3.57 |
| 200-Day Average | $3.63 |
| 52-Week Range | $2.23 to $6.51 |
| RSI (14 Days) | 61.7 |
| Average Volume (20 Days) | 3.36M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.22x current liabilities.
| Current Ratio | 2.22x |
|---|---|
| Quick Ratio | 1.77x |
| Interest Coverage | 0.83x |
Returns and Efficiency
Return on invested capital is -10.38% over the last 12 months, against a 5-year average of -84.40%.
| Return on Assets (ROA) | -10.35% |
|---|---|
| Return on Invested Capital (ROIC) | -10.38% |
| Return on Capital Employed (ROCE) | -5.07% |
| ROA (5Y Average) | -9.91% |
| ROIC (5Y Average) | -84.40% |
| Asset Turnover | 0.68x |
| Inventory Turnover | 2.16x |
| Receivables Turnover | 9.81x |
| Cash Conversion Cycle | 160 days |
Scores
MNKD has an Altman Z-Score of -4.63, in the distress zone below 1.81, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -4.63 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 4 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $413.37M over the last 12 months.
| Revenue | $413.37M |
|---|---|
| Revenue Growth (YoY) | +31.74% |
| Gross Profit | $313.17M |
| Operating Income | -$11.89M |
| Pretax Income | -$79.61M |
| Net Income | -$74.82M |
| EBITDA | -$3.96M |
| EBIT | -$31.16M |
| Reported EPS (TTM) | -$0.20 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
| Cash and Equivalents | $41.28M |
|---|---|
| Total Debt | $319.45M |
| Net Debt | $278.17M |
| Net Debt Per Share | $0.87 |
| Working Capital | $131.95M |
| Shareholder Equity | -$37.27M |
| Tangible Book Value | -$109.79M |
| Total Assets | $722.62M |
| Total Liabilities | $759.88M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $12.16M of capital spending, operating cash flow left -$78.41M of free cash flow.
| Operating Cash Flow | -$66.24M |
|---|---|
| Capital Expenditures | $12.16M |
| Free Cash Flow | -$78.41M |
| FCF Per Share | -$0.24 |
| Depreciation and Amortization | $27.45M |
| Share Repurchases | $5.84M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is -2.88%, against a 5-year average of -17.14%.
| Gross Margin | 75.76% |
|---|---|
| Operating Margin | -2.88% |
| Pretax Margin | -19.26% |
| Net Margin | -18.10% |
| EBITDA Margin | -0.96% |
| EBIT Margin | -7.54% |
| FCF Margin | -18.97% |
| Gross Margin (5Y Average) | 61.46% |
| Operating Margin (5Y Average) | -17.14% |
| Net Margin (5Y Average) | -37.91% |
Growth
Revenue grew 51.80% a year over 3 years.
| Revenue Growth (3Y CAGR) | +51.80% |
|---|---|
| Revenue Growth (5Y CAGR) | +39.89% |
Dividends and Yields
MNKD does not pay a dividend. Its free cash flow yield is -6.02%.
| FCF Yield | -6.02% |
|---|---|
| Buyback Yield | 0.45% |
| Shareholder Yield | 0.45% |
Stock Splits
The last split was a 1-for-5 reverse split on Mar 3, 2017.
| Last Split Date | Mar 3, 2017 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:5 |
Peer Position
Against 8 similar companies, MNKD has the 7th highest P/S.
P/S RatioPeer median 10.2x
ROICPeer median -34.91%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +12.82%
| P/S Ratio | 3.2x vs 10.2x median |
|---|---|
| ROIC | -10.38% vs -34.91% median |
| Revenue Growth (Trailing 4 Quarters, YoY) | +31.74% vs +12.82% median |
Analyst Forecast
Consensus estimates put revenue growth at 22.01% and EPS growth at 50.00% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +22.01% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | +50.00% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About MNKD
What is MNKD's market cap?
MannKind has a market cap of $1.27B. Its enterprise value, which adds debt and subtracts cash, is $1.55B.
How many shares of MNKD are outstanding?
MannKind has 320.18M shares outstanding. The count is up 4.36% from a year earlier.
Does MNKD pay a dividend?
No. MannKind does not pay a dividend.
How much debt does MNKD have?
MannKind has $319.45M of total debt and $41.28M of cash and equivalents, a net debt position of $278.17M.
MNKD pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors